This study is looking at whether a custom-made, high-CBD product called Cannabidiol, which contains no THC, can help people with bipolar disorder (type I or II) who also experience anxiety. Researchers want to see if taking Cannabidiol for four weeks can reduce anxiety levels. You might be able to join if you are 18-65 years old, speak English, have bipolar disorder, experience at least moderate anxiety, and are already on stable medication for your condition. The main goal is to measure changes in your self-reported anxiety after four weeks of taking Cannabidiol. This is a small, early-stage study with 25 participants, and its current status is unclear.

Study design

This is an open-label study, meaning both you and the researchers will know you are receiving Cannabidiol. It plans to enroll 25 participants.

What's involved

You will have a phone pre-screening, followed by a screening visit at the hospital for interviews, questionnaires, a urine test, and a blood draw. If eligible, you'll return for a baseline visit with more questionnaires, a cognitive test, and a cheek swab, then take Cannabidiol for four weeks.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome is measured at 4 weeks, which is the duration of the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.